Diagnostic Criteria for Secondary HLH
Secondary hemophagocytic lymphohistiocytosis (HLH) is diagnosed using the same HLH-2004 criteria as primary HLH, requiring 5 of 8 clinical and laboratory parameters to be met, combined with clinical judgment and identification of an underlying trigger (infection, malignancy, or autoimmune disease). 1
The HLH-2004 Diagnostic Criteria
The diagnosis requires 5 of the following 8 criteria 1:
Clinical Criteria:
- Fever (persistent, unexplained)
- Splenomegaly (hepatomegaly may also be present)
Laboratory Criteria:
Cytopenias affecting ≥2 of 3 lineages:
- Hemoglobin < 90 g/L (< 100 g/L in infants < 4 weeks)
- Platelets < 100 × 10⁹/L
- Neutrophils < 1.0 × 10⁹/L
Hypertriglyceridemia and/or hypofibrinogenemia:
- Fasting triglycerides ≥ 3.0 mmol/L (≥ 265 mg/dL)
- Fibrinogen ≤ 1.5 g/L
Hemophagocytosis in bone marrow, spleen, or lymph nodes (no evidence of malignancy)
Low or absent NK cell activity (according to local laboratory reference)
Ferritin ≥ 500 μg/L (though levels of 7,000-10,000 μg/L are more characteristic in adults) 1
Soluble CD25 (sCD25/soluble IL-2 receptor) ≥ 2,400 U/mL 1
Key Distinguishing Features for Secondary HLH
The critical difference between primary and secondary HLH is not in the diagnostic criteria themselves, but in the underlying trigger. Secondary HLH requires identification of an inciting cause 2, 1:
Most Common Triggers in Adults:
- Infections (most prevalent): EBV, CMV, other viruses 1
- Malignancies (especially with increasing age): T-cell/NK-cell lymphomas (35%), B-cell lymphomas (32%), leukemias (6%), Hodgkin lymphoma (6%) 1
- Autoimmune/autoinflammatory conditions (termed MAS-HLH when associated with Still's disease, lupus, vasculitis) 1
Important Clinical Nuances
Diagnostic Sensitivity in Adults:
The most sensitive diagnostic parameters based on adult data are 3:
- Persistent fever (98.96%)
- Hyperferritinemia (94.27%)
- Elevated sCD25 (94.79%)
- Decreased/absent NK cell activity (94.27%)
Cytopenias may not be prominent early in rheumatic disease-associated HLH (only 80.73% overall), making this a potential diagnostic pitfall 3.
When to Suspect Secondary HLH:
Hyperferritinemia should always trigger consideration of HLH in the differential diagnosis. While ferritin > 10,000 μg/L is >90% sensitive and specific in children, this threshold is less specific in adults, requiring integration of multiple clinical features 1.
sCD25 has superior diagnostic performance in adults compared to ferritin (AUC 0.90 vs 0.78), making it a valuable low-cost test 1.
Additional Supportive Findings:
While not part of formal criteria, these findings strengthen the diagnosis 1:
- CSF pleocytosis (mononuclear cells) and/or elevated CSF protein
- Liver biopsy showing chronic persistent hepatitis pattern
- Hepatic enzyme abnormalities (94.27% of patients) 3
- Hypoproteinemia, hyponatremia
- Elevated VLDL/low HDL
- Coagulopathy (75.52% of patients) 3
Critical Management Point
HLH-directed therapy may be initiated even when fewer than 5 criteria are met if clinical suspicion is high, as delay in treatment significantly impacts mortality 1. However, meticulous search for the underlying trigger must continue despite ongoing HLH treatment, as treating the underlying cause is essential for definitive management 1.
Common Pitfall:
Do not confuse secondary HLH with sepsis/SIRS/MODS, as these conditions share overlapping inflammatory phenotypes but require radically different treatments (chemotherapy/immunosuppression for HLH vs. antibiotics/supportive care for sepsis) 4. The key differentiator is quantitative assessment of cytotoxic lymphocyte function and NK cell activity.